Update on feline infectious peritonitis: case studies and case series

spotlight topic:

Case studies and case series

Published 27 September 2023 | Updated 9 August 2024

  • Sase, O. et al. (2024) GS-441524 and molnupiravir are similarly effective for the treatment of cats with feline infectious peritonitis. Frontiers in Veterinary Science, 11. https://doi.org/10.3389/fvets.2024.1422408
  • Allinder, M. et al. (2024) Uroliths composed of antiviral compound GS-441524 in 2 cats undergoing treatment for feline infectious peritonitis. Journal of Veterinary Internal Medicine, 38 (1), pp. 370-374. https://doi.org/10.1111/jvim.16954
  • Pedersen, N. C. et al. (2018) Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. Journal of Feline Medicine and Surgery, 20 (4), pp. 378–392. https://doi.org/10.1177%2F1098612X17729626
  • Taylor, S.S. et al. (2023) Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020–2022). Journal of Feline Medicine and Surgery, 25 (9).  https://doi.org/10.1177/1098612X231194460
  • Lv, J. et al. (2022) Effect of GS-441524 in combination with the 3C-like protease inhibitor GC376 on the treatment of naturally transmitted feline infectious peritonitis. Frontiers in Veterinary Science, 9, no. 1002488. https://doi.org/10.3389/fvets.2022.1002488
  • Pedersen, N. C. et al. (2019) Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. Journal of Feline Medicine and Surgery, 21 (4), pp. 271–281. https://doi.org/10.1177%2F1098612X19825701
  • Green, J., Syme, H. and Tayler, S. (2023) Thirty‐two cats with effusive or non‐effusive feline infectious peritonitis treated with a combination of remdesivir and GS‐441524. Journal of Veterinary Internal Medicine, 37 (5), pp. 1784-1793. https://doi.org/10.1111/jvim.16804
  • Dickinson, P.J. et al. (2020) Antiviral treatment using the adenosine nucleoside analogue GS‐441524 in cats with clinically diagnosed neurological feline infectious peritonitis. Journal of veterinary internal medicine, 34 (4), pp.1587-1593. https://doi.org/10.1111/jvim.15780
  • Krentz, D. et al. (2021) Curing cats with feline infectious peritonitis with an oral multi-component drug containing GS-441524. Viruses, 13 (11), no. 2228. https://doi.org/10.3390/v13112228
  • Zwicklbauer, K. et al. (2023) Long-term follow-up of cats in complete remission after treatment of feline infectious peritonitis with oral GS-441524. Journal of Feline Medicine and Surgery, 25 (8). https://doi.org/10.1177/1098612X231183250
  • Sase, O. (2023) Molnupiravir treatment of 18 cats with feline infectious peritonitis: A case series. Journal of Veterinary Internal Medicine, 37 (5), 1876-1880. https://doi.org/10.1111/jvim.16832
  • Roy, M. et al. (2022) Unlicensed Molnupiravir is an effective rescue treatment following failure of unlicensed GS-441524-like therapy for cats with suspected feline infectious peritonitis. Pathogens, 11 (10), no. 1209. https://doi.org/10.3390/pathogens11101209

Claiming CPD for reading inFOCUS articles

Reading and reflecting on articles can count towards your CPD, and we have a template to help you with the process.

Online full-text available to Library members

A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.